Esophageal Neoplasms: all 1,631 studies
Page 2 of 17. Open to participants first (469), then studies with results posted, then the rest; newest registration first within each.
- Incidence of 106TBL Lymph Node MetastasisRecruitingNCT07165210
- Incidence of 107 Lymph Node MetastasisRecruitingNCT07165184
- dCRT vs. Surgery in Resectable ESCC Patients Achieving cCR/PR After Induction ChemoimmunotherapyRecruitingNCT07162506Phase 2
- Evaluation of Seismocardiography(SCG) for Assessing Fitness and Predicting Outcomes in Oesophageal Cancer SurgeryRecruitingNCT07159711
- Endostatin Adenovirus With Checkpoint Inhibitor in Advanced Head and Neck or Esophageal CancerNot yet recruitingNCT07154108Phase 1
- Brachytherapy With Radiotherapy and Immunotherapy: Guided HDR Trial in Esophageal Squamous Cell CarcinomaRecruitingNCT07152678Phase 2
- HEARTS Trial for Thoracic CancersRecruitingNCT07132918Phase 2
- Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)RecruitingNCT07124351Phase 4
- DESTINY-PANTUMOUR04RecruitingNCT07124000
- Impact of CES1 Genotype on Capecitabine Exposure in Cancer PatientsRecruitingNCT07114627
- A Study of LY4257496 in Participants With Cancer (OMNIRAY)RecruitingNCT07114601Phase 1
- Detection of Upper Gastrointestinal Tumour Depth and Demarcation Using Systemic Administration of Indocyanine Green During Endoscopic Submucosal DissectionRecruitingNCT07108855Phase 1/2
- Non-intubated Versus Intubated Anesthesia in Thoracoscopic Esophagectomy for Esophageal CancerNot yet recruitingNCT07104838Not applicable
- Development and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated GastroscopyRecruitingNCT07104214
- A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid TumorsRecruitingNCT07090499Phase 1
- Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid TumorsRecruitingNCT07071103Phase 2
- Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEARecruitingNCT07070466Phase 2
- The Intensive Nutritional Support in Esophageal Cancer Undergoing Neoadjuvant TherapyNot yet recruitingNCT07067359Not applicable
- Non-gastric Conduit Reconstruction After EsophagectomyNot yet recruitingNCT07064655
- Multimodal Deep Learning for Predicting Treatment Response to Neoadjuvant Chemoimmunotherapy in Esophageal CancerRecruitingNCT07063901
- Oncolytic Virus in Esophageal Squamous Cell CarcinomaRecruitingNCT07061704Phase 1/2
- Distance-Based Exercise to Preserve Function and Prevent DisabilityRecruitingNCT07059884Not applicable
- Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell CarcinomaRecruitingNCT07054086
- Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or SurgeryNot yet recruitingNCT07046221Phase 2
- Comparison of Endoscopy and Esophagram for the Routine Evaluation of Anastomosis After McKeown EsophagectomyRecruitingNCT07043491
- Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.RecruitingNCT07039526Phase 2
- The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer ImmunotherapyRecruitingNCT07039474
- Chemoradiation Plus Iparomlimab Consolidation in Older With ESCCRecruitingNCT07038629Phase 2
- Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis TechniquesRecruitingNCT07035587
- Definitive Proton Radiotherapy Combined With Chemotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase I Clinical StudyNot yet recruitingNCT07034118Phase 1
- Developing an Ecological and Tailored Nutritional Intervention to Improve Quality of Life in Esophageal Cancer SurvivorsRecruitingNCT07024849Not applicable
- Tislelizumab Combined With Chemotherapy for the Perioperative Treatment of Esophageal Squamous CarcinomaNot yet recruitingNCT07019181Phase 2
- Comparison of Drainage Methods in Minimally Invasive Esophagectomy (DEMURE）RecruitingNCT07004634Not applicable
- Timing of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric AdenocarcinomaRecruitingNCT07000253Phase 2
- The Vanguard Study: Testing a New Way to Screen for CancerRecruitingNCT06995898Not applicable
- Adaptive Neoadjuvant Therapy for Esophageal CancerEnrolling by invitationNCT06990178Not applicable
- Radiation-induced Toxicity of the HeartNot yet recruitingNCT06986291Not applicable
- Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Esophageal CarcinomaRecruitingNCT06979869
- Sintilimab Plus Apatinib and SOX as First-line Treatment in Patients With AFP Gastric or Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT06973330Phase 2
- The Effect of Neoadjuvant Chemoimmnotherapy Combined With Node Sparing Radiotherapy for cT3N+ ECNot yet recruitingNCT06965829Phase 2
- Use of Different Enteral Feeds to Impact on Chyle Leaks in OesophagectomyNot yet recruitingNCT06965205Not applicable
- CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCCRecruitingNCT06964568Phase 3
- Clinical Study on the Treatment of Anorexia and Cachexia in Advanced Gastric and Esophageal Cancer With Nanosized Megestrol Acetate Combined With ImmunochemotherapyNot yet recruitingNCT06963593Phase 4
- A Study of MT-4561 in Patients With Various Advanced Solid TumorsRecruitingNCT06943521Phase 1/2
- Evaluation of Efficacy and Safety De-escalation Versus Standard Adjuvant Chemotherapy in Patients With Low Risk Localized Gastroesophageal AdenocarcinomaNot yet recruitingNCT06933966Phase 2
- Circulating Tumor DNA MRD-Guided Adjuvant Therapy for Curatively Resected Locally Advanced Esophageal Squamous Cell CarcinomaNot yet recruitingNCT06914011Phase 3
- IDOV-Immune for Advanced Solid TumorsRecruitingNCT06910657Phase 1
- PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal CancerRecruitingNCT06906887Phase 2
- Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant TherapyNot yet recruitingNCT06889402
- Thoraco-laparoscopic Partial Esophagogastrectomy for Management of Esophageal CancerNot yet recruitingNCT06879483Not applicable
- Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal)RecruitingNCT06872515Not applicable
- A Multicenter Phase II Clinical Study of Neoadjuvant Use of Camrelizumab in Combination With Chemotherapy for Organ Preservation in Esophageal CancerRecruitingNCT06869226Phase 2
- A Single-arm, Open, Single-center Exploratory Study of Adebrelimab (SHR-1316) in Combination With Chemotherapy for the Perioperative Treatment of Locally Advanced Resectable Esophageal Squamous CarcinomaRecruitingNCT06869213Phase 2
- Luso-Cor Stent Compared to Other Endoscopic Techniques for Management of Fistulas and Anastomotic Dehiscences(ES-LCCE-UDFM)Enrolling by invitationNCT06862479
- Postoperative Adjuvant Therapy for CT041 Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma PatientsNot yet recruitingNCT06857786Phase 1
- Evaluation of Neoadjuvant Therapy Efficacy and Postoperative Pathological Indicators in Esophageal Cancer Using CT and Multimodal MRINot yet recruitingNCT06833775
- Personalized Nutrition Counseling and Nutritional Status of Esophageal Cancer and HNSCC Patients Undergoing CCRTRecruitingNCT06829095
- Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early DiagnosisRecruitingNCT06822413
- Mechanistic Study on the Diagnosis of Esophageal Cancer Lymph Node Metastasis Using Spectral CT, Multimodal MRI, FAPI PET-CT, Pathology, and AI Evaluation SystemNot yet recruitingNCT06818214
- "Less-is-more in Barrett-surveillance" Care Evaluation of Barrett's Patients With Low-Risk in Whom Endoscopic Surveillance is Stopped. The BLISS Project.RecruitingNCT06803147
- COMBO Endoscopy Oropharyngeal Airway Reduces Hypoxia During Sedated Gastrointestinal Endoscopy in Obese Patients: A Multicenter, Randomized, Controlled Clinical TrialRecruitingNCT06796764Not applicable
- A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA MonitoringRecruitingNCT06792786Not applicable
- Precision Palliative Care for Patients With Advanced Esophageal CancerRecruitingNCT06787313
- Phase I Study of BC008-1A Injection in Patients With Advanced Solid TumorsRecruitingNCT06773507Phase 1
- BC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma.RecruitingNCT06773312Phase 1
- A Phase II Clinical Study to Evaluate HLX43 in Patients With Recurrent/Metastatic ESCC Failed or Intolerance to Standard TherapyRecruitingNCT06769113Phase 2
- Tislelizumab Combined with SOX Regimen in the Treatment of Locally Advanced Gastric Cancer/gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT06764251Phase 2
- A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)RecruitingNCT06760819Phase 2
- DCE-MRI Based on 4D Free Breathing for Predicting Preoperative Neoadjuvant Chemoradiotherapy for Esophageal CancerRecruitingNCT06755866Not applicable
- A Trial of the Combination of Afatinib and Palbociclib in Previously Treated Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT06753747Phase 1/2
- Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic RefluxRecruitingNCT06746623Not applicable
- A Prospective, Randomized, Open, Phase II Clinical Study of Chidamide in Combination with Camrelizumab and Apatinib for Advanced Esophageal CancerNot yet recruitingNCT06745193Phase 2
- Outside the Cage (OTC) Robotic EsophagectomyNot yet recruitingNCT06735638Phase 1
- Textbook Outcomes After Oesophagectomy in Regional AustraliaNot yet recruitingNCT06721715
- Target-specific immunoPET Imaging of Digestive System CarcinomaRecruitingNCT06715839Not applicable
- Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric Junction CancerRecruitingNCT06713993
- Lead-212 PSV359 Therapy for Patients With Solid TumorsRecruitingNCT06710756Phase 1/2
- A Phase 2 Study of Zanidatamab in Patients With HER2-expressing TumorsRecruitingNCT06695845Phase 2
- Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening TestsRecruitingNCT06693622
- Tislelizumab as Single-Agent Neoadjuvant Immunotherapy in Resectable Esophageal Squamous Cell CarcinomaNot yet recruitingNCT06692270Phase 2
- Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant TumorsEnrolling by invitationNCT06690216Phase 1/2
- Metformin as a Metabolic Intervention in Oesophageal Adenocarcinomas to Improve Response to Neoadjuvant ChemoradiotherapyRecruitingNCT06687876Phase 2
- Cadonilimab Combined With Anlotinib Followed by Radiotherapy in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma (CAR-RMEC)Not yet recruitingNCT06681285Phase 2
- TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCCRecruitingNCT06676449Phase 3
- Brodalumab in the Treatment of Immune-Related Adverse EventsRecruitingNCT06673329Phase 1
- SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal CancerNot yet recruitingNCT06666166Phase 2
- Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1RecruitingNCT06649474Not applicable
- Fruquintinib in Combination With Tislelizumab Followed by Radiotherapy in Esophageal Squamous Cell CarcinomaRecruitingNCT06646588Phase 2
- PET-imaging of Two Vartumabs in Patients With Solid TumorsRecruitingNCT06645808Early Phase 1
- Tranilast Vs. Steroids to Prevent Esophageal Stricture (TAPES) After Endoscopic Resection for Superficial NeoplasmsNot yet recruitingNCT06643689Phase 2
- Multi-omics Based Prediction of Treatment Response to Immunotherapy Combined with Chemotherapy in Advanced Gastric/Gastroesophageal Junction Cancer.RecruitingNCT06642857
- Focal Cryoballoon Ablation for Malignant DysphagiaRecruitingNCT06618742Not applicable
- Pan-tumor MRD StudyRecruitingNCT06605404
- Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMAEnrolling by invitationNCT06603987Phase 1/2
- Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCCRecruitingNCT06601309Phase 2
- Maintenance Chemotherapy With S-1, Locally Advanced Esophageal Cancer Receiving Definitive CCRTNot yet recruitingNCT06598917Phase 2
- Home Monitoring During ChemoradiationRecruitingNCT06597240
- Lymphocyte-sparing Thoracic Radiotherapy for Esophageal Squamous Cell CarcinomaRecruitingNCT06596954Not applicable
- The Efficacy and Safety of LM-302 in Combination With Candonilimab and Capecitabine for First-Line Treatment in Patients With Unresectable Advanced, Recurrent, or Metastatic CLDN18.2-Positive Gastric or Gastroesophageal Junction AdenocarcinomaRecruitingNCT06587425Phase 2
- Efficacy and Safety of Penpulimab Combined With Anlotinib and ChemotherapyRecruitingNCT06586242Phase 2